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Hearing impairment caused by ototoxic insults, such as noise or gentamicin is a worldwide health problem. As the molecular
circuitries involved are not yet resolved, current otoprotective therapies are rather empirical than rational. Here,
immunohistochemistry and western blotting showed that the cytoprotective protein survivin is expressed in the human and
guinea pig cochlea. In the guinea pig model, moderate noise exposure causing only a temporary hearing impairment transiently
evokedsurvivinexpressioninthespiralligament,nerveﬁbersandtheorganofCorti.Mechanistically,survivinupregulationmay
involve nitric oxide (NO)-inducedAkt signaling, asenhanced expression of the endothelial NO synthase and phosphorylated Akt
were detectable in some surviving-positive cell types. In contrast, intratympanic gentamicin injection inducing cell damage and
permanent hearing loss correlated with attenuated survivin levels in the cochlea. Subsequently, the protective activity of the
human and the guinea pig survivin orthologs against the ototoxin gentamicin was demonstrated by ectopic overexpression and
RNAi-mediated depletion studies in auditory cells in vitro. These data suggest that survivin represents an innate cytoprotective
resistor against stress conditions in the auditory system. The pharmacogenetic modulation of survivin may thus provide the
conceptual basis for the rational design of novel therapeutic otoprotective strategies.
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Hearing impairment is a multifactorial disorder, caused
by both genetic and environmental factors, including noise
and ototoxic drugs, such as aminoglycoside antibiotics.
1,2
In developing countries, low cost and high efﬁcacy make
gentamicin the common choice for treatment of bacterial
infections. Although ototoxicity is an important dose-limiting
side effect, the beneﬁts provided by gentamicin often out-
weigh the risks.
1 Also, transtympanic injection of gentamicin
at low concentrations is widely used for the treatment of
Me ´nie `re’s disease.
1 Ototoxicity is often the consequence of
irreversible drug-induced cell death in the cochlea, affecting
also auditory and vestibular sensory cells. Although the
detailed molecular mechanism underlying gentamicin-
induced cytotoxicity have not been resolved in detail, the
generation of free radicals by iron-gentamicin complexes has
received strong support because anti-oxidants attenuate
aminoglycoside-induced hearing loss.
1,3,4
Similarly, acoustic trauma can induce temporary or
permanent hearing impairment. In particular, a temporary
auditory threshold shift caused by moderate noise exposure
isclinicallyrelevantforindustryandotherenvironmentswhere
such sound levels produce physical and psychological stress.
Besides mechanical damage, acoustic trauma causes ex-
citotoxicity, followed by metabolic disturbances.
4,5 Noise
exposure not only affects hair cells, but also auditory nerve
ﬁbers and the stria vascularis, critical for the maintenance of
cochlearhomeostasis.Atthemolecularlevel,acoustictrauma
inter alia results in the formation of reactive oxygen/nitrogen
species and a calcium overload, which may culminate in
triggering apoptotic and/or necrotic pathways.
4,5
Hence, important similarities in the ototoxic effects induced
by noise and aminoglycosides exist, and both appear to
converge in affecting pro- and anti-apoptotic cellular
responses.
5–7 Unfortunately,the moleculareffectorsmediating
these biological responses remain poorly understood. Several
pro-apoptotic mechanisms, including stress-activated protein
kinasepathways,havebeensuggestedtocontributetohearing
impairment.
5–7 In contrast, the knowledge on cytoprotective
cellularresponsescounteractingpermanentdamageissparse.
Thesegapsintheexistentknowledgehavelimitedtheresearch
on otoprotective strategies mainly to prevention and to an
empirical matter of trial and error.
7–9
In general, modulation of programmed cell death (PCD)
can be achieved by the dynamic expression of pro- and
anti-apoptotic BCL-2 protein family members and apoptosis
inhibitor proteins, such as survivin.
10–12 Survivin’s dual
function as an apoptosis inhibitor and a mitotic regulator
protect cancer cells against caspase-dependent as well as
independent death pathways.
11,12 Recent evidence suggests
that survivin may also be expressed in non-malignant
differentiated tissues, potentially executing cytoprotective
functions against various stress conditions.
13–15
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www.nature.com/cddisAs neither survivin expression in the inner ear nor its
potential clinical relevance for the pathophysiology of hearing
impairment has been investigated so far, we here used
comprehensive experimental approaches to investigate sur-
vivin’s role in the auditory system. Our study provides the ﬁrst
evidence that the physical and chemical stress-induced
modulation of survivin may represent an innate mechanism
to protect the inner ear against ototoxic insults.
Results
Survivin expression in the human cochlea. To provide
a rationale for an otoprotective role of survivin as well as
its potential clinical relevance, we ﬁrst examined survivin
expression in mid-modiolar cross-sections of human cochlea
by immunohistochemistry (IHC) (Figure 1). Employing our
established IHC protocol used to study survivin’s expression
and function of,
16–19 survivin was speciﬁcally detectable as a
cytoplasmic and nuclear protein in the organ of Corti, the
lateral wall, interdental cells of the Limbus, the spiral
ganglion, the Schwann cells, as well as in nerve ﬁbers of
the osseous spiral lamina regions (Figure 1a–d, and data not
shown). No immunoreactivity was observed in cells of the
inner and outer sulcus and the Reissner’s membrane.
Survivin was also detectable in the same cell types in the
guinea pig cochlea (Figure 1a0–d0). As staining speciﬁcity is
highly critical for immuno(histo)logical studies, we veriﬁed
that the used antibodies and staining protocols reliably detect
the survivin orthologs. No IHC signal was detectable upon
omission of the primary a-survivin Ab or preabsorption of the
a-survivin Ab with recombinant human survivin-GFP protein
(data not shown). A single band with the molecular weight
predicted for survivin was detectable by immunoblot analysis
in whole cell lysates from proliferating mouse and guinea pig
ﬁbroblasts as well as from a human tumor, which served as
the positive control (data not shown).
Survivin is transiently upregulated upon noise exposure
in the guinea pig cochlea. The guinea pig is used as an
accepted animal model to study the effects of ototoxic insults
and otoprotective strategies. As we hypothesized that
survivin may represent an innate otoprotective mechanism,
we analyzed the correlation of noise-induced temporary
hearing loss with survivin levels.
As there is an ongoing discussion, whether immunohisto-
chemical detection methods allow a quantitative analysis of
protein levels in situ, we ﬁrst veriﬁed that our computer-
assisted quantiﬁcation of the immunoreactivity is suitable
to detect changes in protein levels. For this purpose, we
microinjected increasing amounts of an autoﬂuorescent
recombinant GFP–GST protein into cells. Subsequently, we
used a-GFP Ab to immunohistochemically visualize the levels
of injected protein. When comparing protein levels based
on the quantiﬁcation of GFP-ﬂuorescence and on IHC-based
analysis, we found that both measurements correlated with
the amounts of ectopically applied protein (data not shown).
Survivin expression was examined in mid-modiolar
cochlea cross-sections (Figure 2d) from unexposed animals
(groupNI), 1h(70/90dBfor1h,groupNII/III) or2hafter noise
exposure (90dB for 1h, group NIV) (Figure 2a). In addition,
Figure1 Survivinexpressioninvariousregionsofthehuman(a–d)andtheguineapig(a0–d0)cochleavisualizedbyIHC.(a/a0)Overview.(b/b0)Survivinisdetectableinall
cell types in the organ of Corti, except the cuticular plates of pillar cells and in Claudius cells. (c/c0) In the lateral wall, survivin immunoreactivity was observed in the spiral
ligament and the stria vascularis. (d/d0) Survivin expression in the spiral ganglions. id, interdental cells; is, inner sulcus; lw, lateral wall; nf, nerve ﬁbers; oC, organ of Corti; os,
outersulcus;Rm,Reissner’smembrane;sg,spiralganglion;sl,spiralligament;SM,scalamedia;ST,scalatympany;sv,striavascularis;SV,scalavestibuli.Scalebars,50mm
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Cell Death and Diseasewe veriﬁed the physiological effect of acoustic trauma by
recording the auditory brainstem responses (ABRs) before
and 2h after noise exposure, revealing a mean hearing
impairment of 33dB (Figure 2b). Notably, treatment resulted
in a temporary threshold shift only, and the animal’s ABR fully
recovered 7 days post exposure (data not shown).
Analysis of the data obtained by computer-assisted IHC
indicated a noise-induced upregulation of survivin expression
in the spiral ligament (Po0.005) as well as in the nerve ﬁbers
(Po0.005)(Figure2e,fandTable1).Thisincreaseofsurvivin
was evident already 1h after noise exposure in the cell types
of the lateral wall for all three cochlea turns, and further
increased 2h after 90dB noise exposure (Figure 2e and
Table 1). In addition, increased survivin expression was
observed in the organ of Corti, interdental cells of the
limbus, ganglion cells as well as in the stria vascularis,
although without reaching statistical signiﬁcance (Table 1).
No signiﬁcant differences in expression were found when
comparing the different cochlea turns (Table 1). The noise-
induced survivin expression was conﬁrmed by an indepen-
dent method, as enhanced survivin levels were detectable by
immunoblot analysis of lysates from macro-dissected whole
cochleae (Figure 2c).
eNOS and NO levels are enhanced by auditory trauma.
Reactive oxygen and nitrogen radicals are involved in
acoustic trauma.
4 Thus, we analyzed the levels of endo-
thelial NO-synthase (eNOS) and NO concentrations
following noise exposure. Notably, eNOS was found in
several survivin-expressing cell populations, such as
the organ of Corti, the nerve ﬁbers and the lateral wall
(Figure 3a–e). As the eNOS-mediated generation of NO
appears to be an early event prerequisite for the induction of
survivin,
17,19 we studied controls (group NI) and animals after
noise exposure (90dB for 1h, group NIII). Enhanced eNOS
was observed in the organ of Corti (Po0.005), the nerve
Figure 2 Survivin induction by noise exposure. (a) Overview of treatment and animal groups. Guinea pigs were either unexposed (NI) or exposed to 70dB (NII) or 90dB
(NIII/IV) SPL for 1h. Bullae were removed at the indicated time points (arrows). (b) ABR recording revealed a mean hearing impairment of 33dB in animals 2h after noise
exposure (90dB SPL for 1h, n¼6, group NVI) compared to unexposed controls (n¼8, group NI). Columns, mean; bars, ±S.D. ***Po0.005. (c) Noise-induced survivin
expression in whole cochleae lysates shown by immunoblot analysis using the a-survivin Ab. Actin served as loading control. (d) Schematics of a cochlear mid-modiolar
section.Thecochleaisdividedintothreeﬂuidcompartments:thescalavestibuli(SV),thescalamedia(SM)andthescalatympany(ST),seperatedbytheReissner’s(Rm)and
thebasalmembrane(bm),respectively.TheouterwalloftheSMislinedbythelateralwall(lw).TheorganofCorti(oC)containsthesensoryepitheliacomprisedoftheauditory
hair cells, which are innervated by the nerve ﬁbers (nf), and the spiral ganglion neurons (sg). (e/f) Survivin expression before and after acoustic trauma analyzed by IHC.
Relative immunoreactivity is indicated for the ﬁrst cochlea turn (t1). (e) Enhanced survivin levels were evident in the spiral ligament as well as in the nerve ﬁbers already 1h
after acoustic trauma, and further increased 2h after 90dB SPL exposure. Columns, mean; bars, ±S.D. **Po0.01. (f) Representative IHC-micrograph demonstrating
enhanced survivin levels in the spiral ligament following acoustic trauma. Scale bar, 50mm
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Cell Death and Diseaseﬁbers (Po0.05) as well as in both parts of the lateral wall, the
stria vascularis (Po0.05) and the spiral ligament (Po0.05),
mostly in all three cochlea turns (Figure 3e, Table 1). In
addition, increased NO concentrations were found in organ
culture supernatants from the noise-exposed animals for the
organ of Corti (NO2
  (562nM±231) versus (331nM±128))
and for the lateral wall (NO2
  (737nM±192) versus
(356nM±136)) (NIII versus NI) (Figure 3f).
Previously, we have shown that low NO concentrations
enhance survivin expression in tumor cells by stimulating Akt
signaling.
17,19 Indeed, IHC analysis not only revealed
increased levels of phosphorylated Akt (pAkt) in different
cochlea regions (Figure 3g and h), but also in eNOS-
expressing cells, such as the nerve ﬁbers and ganglion cells
(Figure 3j and k). Notably, these cell types also displayed
increased survivin levels subsequent to acoustic trauma.
Hence, noise-induced stress results in elevated eNOS
levels and increased NO concentrations in the cochlea, which
subsequently may contribute to an unpregulation of survivin
via Akt signaling.
Gentamicin-induced ototoxicity attenuates survivin
expression. To further study the role of survivin also in
aminoglycoside antibiotic-induced permanent hearing loss,
we analyzed its expression following intratympanic genta-
micin injection 7 days post treatment. This time point was
selected because we showed that injection of low gentamicin
concentrations resulted in a permanent hearing impairment
7 days post treatment.
20 First, a gentamicin-induced perma-
nent threshold shift was veriﬁed by ABR recording, revealing
a mean hearing impairment of 24dB in gentamicin
(group GI) versus saline-injected control animals (group
GII) (Figure 4a). Survivin levels were quantitated by IHC and
data analysis indicated a reduction in survivin expression in
the organ of Corti (Po0.005), the spiral ganglion (Po0.005),
the stria vascularis (Po0.005) as well as in the spiral
ligament (Po0.005) for the ﬁrst cochlea turn (Figure 4b, c
and Table 1). Hence, the gentamicin-induced permanent
hearing impairment correlated with attenuated survivin
levels.
Survivin protects against ototoxin-induced cyto-
toxicity. Aminoglycosides contribute to hearing loss by
triggering apoptosis through caspase-dependent as well as
independent mechanism (Figure 5b).
5,7 Although the cyto-
protective activity of survivin against chemotherapy-based
anti-cancer treatments has been shown, its function against
ototoxin-induced PCD has not been investigated. As the
coding sequence of the guinea pig (Gp) survivin gene as well
as its biological functions were not known, we cloned the
respective cDNA, revealing an open reading frame encod-
ing for a protein of 142 amino acids. The survivinGp
protein displays a high homology to the human and murine
ortholog (GenBank accession number: GQ496319). Ectopic
expression of a survivinGp-GFP fusion protein conﬁrmed
the typical intracellular localization known for human (Hu)
survivinHu (Figure 5a).
11,12
To demonstrate the protective activity of survivin against
ototoxin-induced cell damage, HeLa and the auditory cell
line HEI-OC1, expressing survivinGp-GFP, survivinHu-GFP or
GFP, respectively, were challenged with gentamicin
(Figure 5c, and data not shown). In GFP-expressing control
cells, treatment triggered apoptosis, whereas overexpression
of survivin from both species signiﬁcantly counteracted PCD
as determined by quantitating apoptotic nuclei and caspase-3
activity (Figure 5c, and data not shown). Transgene expres-
sionwasveriﬁedbyﬂuorescencemicroscopyandimmunoblot
analysis,andsimilarresultswereobtaineduponexpressionof
murine survivin (data not shown). In addition, the cytotoxic
effects of gentamicin were signiﬁcantly enhanced by RNAi-
mediated depletion of endogenous survivin (Figure 5d and e).
Discussion
Our study provides evidence for an otoprotective role of the
apoptosis inhibitor protein survivin in the auditory system. We
show that survivin is expressed in cell types critical forhearing
perception in animal models currently employed to study
hearing loss. Non-damaging noise resulted in a transient
increase in survivin levels as well as in enhanced eNOS/NO
concentrations, suggesting a functional correlation. In con-
trast, gentamicin-induced permanent hearing loss correlated
with reduced survivin levels in the cochlea and survivin was
cytoprotective against ototoxins in vitro. As the mammalian
cochlea is unable to regenerate upon damage, these ﬁndings
indicate that survivin appears to be part of a physiological
Table 1 Group comparisons’ signiﬁcance
Ototoxic insult Noise exposure Gentamicin
Group comparison NI versus NIV NI versus NIII GI versus GII
Protein analyzed Survivin eNOS Survivin
Cochlear area P-values
Organ of Corti (oC)
t1 0.2604 o0.0001 0.0006
t2 0.0807 0.0019 0.0010
t3 0.2068 o0.0001 0.3548
Stria vascularis (sv)
t1 0.3221 0.0028 o0.0001
t2 0.2864 0.0115 o0.0001
t3 0.0790 0.0174 0.1016
Spiral ligament (sl)
t1 0.0013 o0.0001 0.0404
t2 0.0005 0.0552 0.6242
t3 0.0034 0.0344 0.3887
Interdental cells (id)
t1 0.3855 0.0500 NA
t2 0.4172 0.1810 NA
t3 0.0873 0.2111 NA
Nerve ﬁbers (nf)
t1 0.0033 0.0517 NA
t2 0.0002 0.0273 NA
t3 0.0002 0.0349 NA
Spiral ganglion (sg)
t1 0.0859 0.3542 o0.0001
t2 0.6222 0.1238 o0.0001
t3 0.3259 0.0157 o0.0001
NA, not analyzed. Differences in survivin and eNOS levels in the three cochlea
turns before and after ototoxic insults quantitated by IHC
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Cell Death and Diseaseprotection mechanism against physical/chemical stress in the
auditory system.
Despite several reports on cell death pathways involved in
hearing loss and presbycusis, knowledge on antagonistic
cytoprotective rescue mechanisms is limited.
5–7 Ectopic
overexpression of the X-linked inhibitor of apoptosis protein
has been reported to counteract apoptosis in the cochlea,
although the physiological protection mechanism remains to
be demonstrated.
21 For survivin, a large body of evidence has
demonstrated that its function as an apoptosis inhibitor and
member of the chromosomal passenger complex (CPC)
protects cancer cells against chemo-radiation therapy-
induced cell death.
11,12 Although recent data suggest that
survivin may also be expressed in non-malignant tissues and
stem cells, potentially executing cytoprotective functions
against various stress conditions, the molecular details are
notyetresolved.
13,22 Hence,it wouldbeof interesttoexamine
whether the other CPC members, AuroraB-kinase, Borealin
and INCENP are also expressed and modulated by stress
conditions in the auditory system. Here, we found survivin
expression in important transducers of acoustic signals
from and to the central nervous system, as well as in several
non-neuronal cell populations, including the stria vascularis,
critical forthemaintenance ofcochlearhomeostasisandthus,
hearing perception.
As there is an ongoing debate whether survivin is indeed
expressed in post-mitotic non-malignant cells, several control
experiments were performed in this study that substantiated
the speciﬁc detection and IHC-based quantiﬁcation of
survivin in the cochlea, such as the use of negative controls,
preabsorption of Abs, as well as the analysis by immuno-
ﬂuorescence and western blot with appropriate controls.
However, the concerns whether IHC-based approaches
allow to quantify protein expression levels in situ are not
yet resolved. Although we addressed this issue by using a
computer-assisted quantiﬁcation of the immunoreactivity, we
feel that even this method may allow only a semi-quantitative
rather than a quantitative determination of protein levels.
Despite these limitations, we feel that our data justify the
conclusion that stress conditions modulate survivin in the
cochlea. Even though we showed that survivin is a critical
otoprotective factor, this does not rule out the additional
participation of other cytoprotective proteins.
10
Although the detailed molecular pathways involved in
modulating survivin levels remain to be identiﬁed, our data
suggest a role of the eNOS/NO-axis for the noise-induced
Figure3 eNOSandNOlevelsareenhancedbyacoustictrauma.Columns,mean;bars,±S.D.*Po0.05;**Po0.01;***Po0.005.(a–e)eNOSexpressionintheguinea
pig cochlea visualizedby IHC. (a) Overview. (b–d) eNOS was detectable in all cell typesin the stria vascularis,the organ of Corti,nerve ﬁbersand spiral ganglion. Scalebars,
50mm.(e)eNOSexpressionbefore(NI) andafternoise(NIII) in theindicatedcelltypesanalyzedby IHC.Relativeimmunoreactivityisindicatedforthedifferentcochleaturns.
(f)Enhanced[NO2
 ]measuredinthesupernatantoforganculturesfromnoiseexposed(NIII)versuscontrolanimals(NI).(g,h)p-AktexpressionvisualizedbyIHCintheorgan
of Corti,nerveﬁbersandspiral ganglionfollowingnoise exposure (1h, 90db SPL). Scalebars,50mm. (i,j) eNOS expression before (NI) andafter noise(NIII) in theindicated
cell types for the ﬁrst cochlea turn
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Cell Death and Diseaseupregulation of survivin. The concept of a concentration-
dependent biphasic effect of NO signaling is well
accepted.
17,19,23 As shown by others and us, low NO levels,
which may be generated by the physiological expression of
eNOS, can stimulate cellular survival programs inter alia by
the Akt-mediated upregulation of survivin.
17,19,23 Although we
found increased levels of p-Akt in some eNOS/survivin-
positive cell types, the functional role of NO-induced
Akt-phosphorylation needs to be further substantiated. In
particular, the IHC-based detection of phosphorylated proteins
insitufollowingextensiveﬁxationandprocessingstepssuchas
required for the cochlea, needs to be interpreted with caution.
In contrast, high NO concentrations, which may be
generated by high-energetic noise or aminoglycoside anti-
biotics,
24 can induce cell death pathways by activating
mitogen-activated protein-kinases (MAPK) resulting also in
survivin downregulation.
17,19,23 Although, the contribution of
the individual MAPK members, such as the p38-MAPK, the
extracellular signal-regulated kinase or the c-Jun N-terminal
kinase (JNK) to gentamicin-induced survivin downregulation
was not examined in our study, previous reports favor
a critical role for the MAPK pathway in the auditory
system.
6,17,19,23,25,26 Hence, blocking JNK activation by
peptide inhibitors to counteract hearing impairment,
27 might
thus act by also stabilizing survivin pools.
Whether the induction of survivin by subtoxic stress
conditions also have a functional role for the phenomenon of
‘sound conditioning’ remains to be clariﬁed.
28 Recently,
nuclear receptors, such as the estrogen and glucocorticoid
receptor have been implicated in modulating otoprotective
cellular programs.
28–30 As intratympanic dexamethasone
injection is currently employed in the clinics to treat transient
hearing impairment and glucocorticoid receptor response
elements are present in the survivin promoter, clinical efﬁcacy
may also act via inﬂuencing survivin expression.
31
Albeit the molecular details how different (noxious) stimuli
affect survivin expression remain to be resolved, it is
conceivable to speculate that survivin represents a nodal
protein where different pathways involved in the induction or
prevention of hearing loss converge. Enhancing survivin
levels under ototoxic stress conditions may provide a
microenvironment protecting the auditory system against
trauma. Once the damage exceeds a certain threshold, this
cytoprotectiveresistorbreaksdown.Thecloningoftheguinea
pig survivin gene now allows to employ this animal model in
translational hearing research to further dissect the molecular
details and to target this cytoprotective resistor. Our data
suggest that enhancing survivin levels by pharmacogenetic
approaches may be exploited as a potential strategy, not only
tocounteract celldeathbutalsotoaidregenerativeprocesses
in the auditory system.
Materials and Methods
Assessment of hearing function and noise exposure. The auditory
brainstem response (ABR) provides information regarding auditory function and
hearing sensitivity. ABRs were assessed in an acoustically shielded chamber
(Industrial Acoustics Company GmbH, Niederkru ¨chten, Germany) to biaural click
stimuli (duration 100ms, 300 averaged stimuli, from 90dB to 10dB sound pressure
level (SPL) following anesthesia. ABRs were recorded using subdermal recording
electrodes (Viasys Healthcare, San Diego, CA, USA). The hearing threshold was
Figure 4 Gentamicin treatment results in survivin downregulation. Columns, mean; bars, ±S.D. *Po0.05, ***Po0.005. (a) ABR recording revealed a permanent mean
hearing impairment of 24dB in gentamicin (group GI, n¼7) versus saline-injected control animals (group GII, n¼9) 7 days post treatment. (b) Survivin levels in GI and GII
were quantitated by IHC for the ﬁrst cochlea turn 7 day post injection. (c) Representative IHC micrograph illustrating reduced survivin expression in ganglion cells following
gentamicin treatment. Scale bar, 50mm
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Cell Death and Diseasedeﬁned as the lowest intensity at which a visible ABR wave was seen in two
averaged runs and was determined by discrimination of wave Jewitt I, III and V for
bothears.Broadbandnoiseexposurewasprovidedat70or90dBSPLusingplastic
tubes positioned directly in both ear canals near the tympanic membrane. Stimulus
presentation, data recording and analysis were performed using the Spirit2000
Evoked Potential System (Nicolet Biomedical Inc., Madison, WI, USA).
Animals and gentamicin administration. Male, 2-weeks-old BFA-
pigmented guinea pigs (Charles River Laboratories, Wilmington, MA, USA) were
used. Animals were kept at 221C±11C under a 12:12h light–dark cycle, and fed
chow and water ad libitum. Experimental protocols were approved by the local
AnimalCareandUseCommittee.Fortreatments,guineapigswereanesthetizedby
an intraperitoneal injection of ketamine (175mg/kg) and xylazine (10mg/kg)
(BayerAG,Leverkusen,Germany),andthebodytemperaturewasmaintainedusing
light heating. Anesthetized animals received either 4mg gentamicin/ear
(Ratiopharm, Ulm, Germany) by injection through the anterior parts of the
tympanic membrane or equivalent volumes (0.1ml) of saline under microscopic
control.
Organ and primary cell culture. Animals were killed by pentobarbital-
sodium(Narcoren)injectionbeforetissuesremoval.Fororganculture,theorgansof
Cortiandlateralwallswereseparated,incubatedinmicrotiterplates(6h,371C),and
the supernatant was stored at  801C.
20 For primary cell culture, lung tissue
was disaggregated in ﬁbroblast medium (199/Ham’s F-12; 20% fetal calf serum,
antibiotics, 10mg/ml insulin; Gibco BRL, Invitrogen, Darmstadt, Germany)
containing 0.1% collagenase III (Sigma Aldrich, Munich, Germany). Cells were
seeded into tissue culture plates and further cultivated in ﬁbroblast medium.
Nitrite measurement. NO production in organ culture supernatant was
assessed by measuring the oxidation product nitrite by the Griess reaction as
described.
19
Figure 5 Survivin protects against ototoxin-induced cytotoxicity. Columns, mean; bars, ±S.D. from three independent experiments. *Po0.05, **Po0.01, ***Po0.005.
(a)LocalizationofguineapigsurvivinGp-GFPtransfectantsininterphaseandmitoticHeLacellsanalyzedbyﬂuorescencemicroscopy.DNAwasmarkedbyHoechstdye(blue).
Scale bars, 10mm. (b) Induction of apoptosisby gentamicin treatment.In untreated HEI-OC1 cells, mitochondrial integrity is shown by the presenceof the mono- and dimeric
formoftheMitoCapturedye(upperpanel).Gentamicintreatment(1mM,24h)causeslossofmitochondrialintegrityresultinginlossofdimericMitoCapturedyestaining(lower
panel). Scale bar, 10mm. (c) Gentamicin-induced PCD is reduced in survivinGp- and survivinHu-GFP expressing transfectants. Cells transfected with the indicated plasmids
weretreatedwithgentamicin(1mM),andanalyzed24hlater.FragmentednucleiwerevisualizedbystainingwithHoechstdyeandthepercentageofapoptoticcellscountedin
atleast500cells.(d)RNAi-mediatedablationofsurvivinfollowingtransfectionwithsurvivin-(surv)orascrambledcontrol-siRNA(scr)conﬁrmedbyimmunoblotanalysis.Actin
served as loading control. (e) RNAi-mediated attenuation of survivin enhanced gentamicin-induced apoptosis. Cells were transfected with the indicated siRNAs and treated
with gentamicin(1mM, for 24h) 24h later.Fragmentednuclei werevisualized by staining with Hoechstdye, and thepercentageof apoptoticcells countedin at least500 cells
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Cell Death and DiseaseAntibodies (Ab), reagents and treatment. Ab were: Polyclonal rabbit
and monoclonal mouse a (anti)-survivin (NB-500-201/NB-500-205, Novus
Biologicals, Cambridge, UK); anti-b-Actin (A2066; Sigma Aldrich); monoclonal
mousea-eNOSAb(BDTransductionLaboratories, SanJose,CA,USA); polyclonal
a-phospho-AKT (9275, Cell Signaling, Danvers, MA, USA); appropriate HRP-
conjugated secondary Ab (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Cells
were treated with gentamicin (1mM) (Sigma Aldrich) for 24h as described.
17
Tissue preparation and immunohistochemistry. Cochleae were
removed and ﬁxed with 0.2% picric acid, 4% paraformaldehyde and 0.1%
glutardialdehyde for 24h at 41C. For mid-modiolar cross-section preparation, cochlea
were decalciﬁed (EDTA for 3 weeks, 41C), dehydrated by ethanol and xylene and
embedded in parafﬁn.
20 Tissues were processed for IHC as described.
17,19 Antigen
retrieval was performed in a pressure cooker (survivin: EDTA buffer, 10mM, pH 9.0;
eNOS/p-Akt: citrate buffer, 10mM, pH 6.0). For visualization of survivin (polyclonal
a-survivin Ab-diluted 1:1250), p-Akt (polyclonal a-p-Akt Ab-diluted 1:50) or eNOS
(monoclonal a-eNOS Ab-diluted 1:50), the EnVision detection system (Dako GmbH,
Glostrup, Denmark) was used as described.
17,19 Sections were counterstained with
hematoxylin. Negative control slides without primary Ab were included for each staining.
Speciﬁcity of the a-survivin Ab was tested by preincubation of 5mg a-survivin Ab with
100mg immobilized recombinant GST-survivin-GFP protein (4h, 41C). Thesupernatant
wassubsequentlytestedbyIHC.RecombinantGST-survivin-GFPproteinwasprepared
as described.
18 Staining procedures against a speciﬁc antigen were performed in a
single experiment for all sections to minimize experimental variations.
Human tissue. Human cochleae were obtained from a female tumor patient
and from a corpse (male, 50 years of age; preparation o3h post mortem) at the
ENT Department of the University Hospital of Mainz. Studies of human tissue
biopsies were performed according to the requirements of the local ethics
committee, and informed consent was obtained in accordance with the Declaration
of Helsinki.
RNA extraction, cDNA cloning and survivin expression
plasmids. Total RNA extraction, puriﬁcation and cDNA synthesis were
performed as described.
32 The cDNA of the guinea pig survivin gene was cloned
using PCR primers designed from highly conserved regions in the 50- and 30-UTRs
of the mouse, rat and human survivin genes using the primers 50conS (50-AAA
GGATCCACATGGGGGCCCCGTCGTTGCC-30) and 30conS (50-AAAGCTAGCC
TCCAAGGCGGCCAGCTGCTC-30)o r3 0conSstop (50-AAAGCTAGCTCACTCC
AAGGCGGCCAGCTGCTC-30), respectively. PCR products were cloned into
pGEM-T-easy (Promega, Madison, WI, USA), and the sequence of the survivinGp
ORFdeterminedbysequenceanalysis.Forectopicexpression,thecodingregionof
survivinGp was ampliﬁed by PCR and cloned into plasmid pc3-GFP as described,
18
resulting in the pc3survivinGp and pc3survivinGp-GFP expression plasmids.
Plasmids were veriﬁed by sequence analysis.
18 Eukaryotic expression constructs
for GFP and GFP-tagged versions of human and murine survivin were reported.
16
Cells, transfection, microinjection, microscopy and image
analysis. HeLa and Vero cells were maintained and transfected as
described.
17 The organ of Corti-derived cell line HEI-OC1 was cultured at 331C.
6
Observation, image analysis and quantiﬁcation of protein localization were
performed as described.
18,33 Preparation and microinjection of recombinant
GST–GFP fusion proteins were performed as described in detail.
18 DNA/cell
nuclei were visualized by staining with Hoechst 33258 (Sigma Aldrich).
18 At least
100 ﬂuorescent cells in three independent experiments were examined.
RNAi. Double-stranded siRNAs (Eurogenetec, Ko ¨ln, Germany) directed against
human survivin or a scrambled control were used to downregulate endogenous
survivin as described.
17
Protein extraction and immunoblot analysis. Preparation of cell
lysates and tissue extraction from tumor biopsies or guinea pig cochleae were
carried out as described.




Computer-assisted IHC quantiﬁcation. Quantiﬁcation of IHC staining
was performed as described.
34 Brieﬂy, slides were scanned using brightﬁeld
imaging at 40-fold magniﬁcation with an Axiovert-200 microscope (Zeiss, Jena,
Germany), and images were recorded with a 3-CCD-DXC-390P camera (Sony)
keeping capture settings constant. Automated analysis of 24-bit RGB images with
a resolution of 1mm/pixel was performed using Photoshop.V7 (Adobe Systems,
SanJose,CA,USA).Toquantifyproteinexpressionlevelsinaspeciﬁccochlearregion,
the respective digitized images were imported and analyzed in a common PSD ﬁle.
Immunoreactive areas were selected by color sampling using a color dropper tool with
a tolerance level of 15, and pixel numbers and intensities were obtained from the color
histogram. To determine the relative immunoreactive area (RIA), the number of
selected pixel was divided by the pixel number representing the total surface of the
speciﬁc cochlear region. The RIA was multiplied with the background-corrected mean
pixel intensity (MPI), resulting in the relative immunoreactivity (RIR¼RIA MPI)
expressed in arbitrary units (AU). Eight consecutive sections per cochlea turn were
analyzed for each animal blindly with respect to treatment.
Statistics. To analyze the IHC quantiﬁcation data, mean values and S.D. in all
subgroups as well as for group comparisons were computed using the two sample
t-tests. We ﬁtted a mixed linear model, taking into account that each animal
contributed several measurements to the analysis using PROC MIXED from SAS
9.2 (SAS Institute Inc., Cary, NC, USA). For all cell culture experiments, a paired
Student’s t-test was performed, representing data from three independent
experiments done in triplicate. Data are presented as mean values with S.D.
P-values o0.05 were considered signiﬁcant.
Measurement of apoptosis and cell vitality. Assessment of apoptosis
was performed by analysis of mitochondrial integrity using the MitoCapture
dye (PromoCell) and quantitation of caspase-3 activity as described.
17 Apoptotic,
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